AI Being Used With Ultrasound To Treat Giant Cell Arteritis and Mesogen's Development Of RPE Patches To Potentially Treat Macular Degeneration

Dr. Jay Avasarala (University of Kentucky Medical Center - Lexington, KY)

Mesogen (The Woodlands, TX)

Dr. Jay Avasarala, professor of neurology and director of the Multiple Sclerosis and Neuroimmunology Center at the University of Kentucky Medical Center in Lexington, explains how artificial intelligence can be used with point-of-care ultrasound (POCUS) to treat Giant Cell Arteritis.

Dr. Michael Riddle, chief executive officer of Mesogen in The Woodlands, Texas, explains how bone marrow-derived stem cells can be used in retinal pigment epithelium (RPE) patches to potentially treat macular degeneration.

7/14/2024 Podcast (Click Image Below)